Siemens expands opioid testing menu with fentanyl assay

By staff writers

January 16, 2020 -- Siemens Healthineers has incorporated the ARK fentanyl assay into its clinical chemistry analyzers to facilitate the detection of fentanyl during opioid testing.

The test is capable of detecting fentanyl and its principal metabolite norfentanyl. Being able to identify both fentanyl and norfentanyl prolongs the time window for detecting fentanyl in urine with chemistry analyzers, giving laboratories more time to identify true positives, according to the company.

The assay is currently available on a variety of chemistry analyzers by Siemens, including its Atellica, Viva, and Dimension Vista series.

Siemens offers liver fibrosis blood test in U.S.
Siemens Healthineers said it is now providing its Enhanced Liver Fibrosis (ELF) testing service in 49 U.S. states, Washington, DC, and Puerto Rico.
Siemens overcomes lagging Diagnostics numbers in Q4
Despite lagging performance in its Diagnostics business, Siemens Healthineers posted strong overall financial results for its fourth quarter, with revenue...
Profitability dips at Siemens Diagnostics, division chief to leave
Siemens Healthineers saw profit decline at its Diagnostics unit for the third quarter, as the company experienced issues related to the ramp-up of its...
Siemens builds on diabetes testing
Siemens Healthineers has released a hemoglobin A1c test that it believes will help clinicians diagnose and monitor patients with diabetes evaluated with...
Urine tests show rising use of deadly stimulant-opioid combos
A study of 1 million urine drug tests processed in the U.S. by the specialty laboratory Millennium Health suggests that users of cocaine and/or methamphetamine...

Copyright © 2020

Last Updated np 1/15/2020 4:52:49 PM